These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7819222)

  • 1. Structural basis for the sequence-specific DNA strand cleavage by the enediyne neocarzinostatin chromophore. Structure of the post-activated chromophore-DNA complex.
    Gao X; Stassinopoulos A; Rice JS; Goldberg IH
    Biochemistry; 1995 Jan; 34(1):40-9. PubMed ID: 7819222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New complex of post-activated neocarzinostatin chromophore with DNA: bulge DNA binding from the minor groove.
    Kwon Y; Xi Z; Kappen LS; Goldberg IH; Gao X
    Biochemistry; 2003 Feb; 42(5):1186-98. PubMed ID: 12564921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMR studies of the post-activated neocarzinostatin chromophore-DNA complex. Conformational changes induced in drug and DNA.
    Gao X; Stassinopoulos A; Gu J; Goldberg IH
    Bioorg Med Chem; 1995 Jun; 3(6):795-809. PubMed ID: 7582957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced formation of a DNA bulge structure by a molecular wedge ligand-postactivated neocarzinostatin chromophore.
    Gao X; Stassinopoulos A; Ji J; Kwon Y; Bare S; Goldberg IH
    Biochemistry; 2002 Apr; 41(16):5131-43. PubMed ID: 11955061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding and cleavage characteristics of the complexes formed between the neocarzinostatin chromophore and single site containing oligonucleotides.
    Stassinopoulos A; Goldberg IH
    Bioorg Med Chem; 1995 Jun; 3(6):713-21. PubMed ID: 7582949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neocarzinostatin chromophore. Assignment of spectral properties and structural requirements for binding to DNA.
    Napier MA; Goldberg IH
    Mol Pharmacol; 1983 Mar; 23(2):500-10. PubMed ID: 6220205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing DNA single strands for single-base bulges with neocarzinostatin chromophore.
    Kappen LS; Xi Z; Goldberg IH
    Biochemistry; 2001 Dec; 40(50):15378-83. PubMed ID: 11735421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective abstraction of 2H from C-1' of the C residue in AGC.ICT by the radical center at C-2 of activated neocarzinostatin chromophore: structure of the drug/DNA complex responsible for bistranded lesion formation.
    Meschwitz SM; Schultz RG; Ashley GW; Goldberg IH
    Biochemistry; 1992 Sep; 31(38):9117-21. PubMed ID: 1390698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution structure of the calicheamicin gamma 1I-DNA complex.
    Kumar RA; Ikemoto N; Patel DJ
    J Mol Biol; 1997 Jan; 265(2):187-201. PubMed ID: 9020982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA conformation-induced activation of an enediyne for site-specific cleavage.
    Kappen LS; Goldberg IH
    Science; 1993 Sep; 261(5126):1319-21. PubMed ID: 8362243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solution structure of a two-base DNA bulge complexed with an enediyne cleaving analog.
    Stassinopoulos A; Ji J; Gao X; Goldberg IH
    Science; 1996 Jun; 272(5270):1943-6. PubMed ID: 8658168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution structure of the esperamicin A1-DNA complex.
    Kumar RA; Ikemoto N; Patel DJ
    J Mol Biol; 1997 Jan; 265(2):173-86. PubMed ID: 9020981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence-specific, strand-selective, and directional binding of neocarzinostatin chromophore to oligodeoxyribonucleotides.
    Lee SH; Goldberg IH
    Biochemistry; 1989 Feb; 28(3):1019-26. PubMed ID: 2523731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bulge-specific cleavage in transactivation response region RNA and its DNA analogue by neocarzinostatin chromophore.
    Kappen LS; Goldberg IH
    Biochemistry; 1995 May; 34(17):5997-6002. PubMed ID: 7537097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sources of hydrogen abstraction by activated neocarzinostatin chromophore.
    Chin DH; Goldberg IH
    Biochemistry; 1993 Apr; 32(14):3611-6. PubMed ID: 8466903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding specificity of post-activated neocarzinostatin chromophore drug-bulged DNA complex studied using electrospray ionization mass spectrometry.
    Gao Q; Cheng X; Smith RD; Yang CF; Goldberg IH
    J Mass Spectrom; 1996 Jan; 31(1):31-6. PubMed ID: 8799259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereochemical control of small molecule binding to bulged DNA: comparison of structures of spirocyclic enantiomer-bulged DNA complexes.
    Hwang GS; Jones GB; Goldberg IH
    Biochemistry; 2004 Jan; 43(3):641-50. PubMed ID: 14730968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular dynamics simulations investigation of neocarzinostatin chromophore-releasing pathways from the holo-NCS protein.
    Zhao X; Wang S; Gao XF; Huang XR; Sun CC
    J Struct Biol; 2010 Jan; 169(1):14-24. PubMed ID: 19747549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solution structure of a designed spirocyclic helical ligand binding at a two-base bulge site in DNA.
    Zhang N; Lin Y; Xiao Z; Jones GB; Goldberg IH
    Biochemistry; 2007 Apr; 46(16):4793-803. PubMed ID: 17388570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA cleavage characteristics of non-protein enediyne antibiotic N1999A2.
    Miyagawa N; Sasaki D; Matsuoka M; Imanishi M; Ando T; Sugiura Y
    Biochem Biophys Res Commun; 2003 Jun; 306(1):87-92. PubMed ID: 12788070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.